Literature DB >> 18282520

Iron homeostasis and erythropoiesis.

Diedra M Wrighting1, Nancy C Andrews.   

Abstract

Erythrocytes require iron to perform their duty as oxygen carriers. Mammals have evolved a mechanism to maintain systemic iron within an optimal range that fosters erythroid development and function while satisfying other body iron needs. This chapter reviews erythroid iron uptake and utilization as well as systemic factors that influence iron availability. One of these factors is hepcidin, a circulating peptide hormone that maintains iron homeostasis. Elevated levels of hepcidin in the bloodstream effectively shut off iron absorption by disabling the iron exporter ferroportin. Conversely, low levels of circulating hepcidin allow ferroportin to export iron into the bloodstream. Aberrations in hepcidin expression or responsiveness to hepcidin result in disorders of iron deficiency and iron overload. It is clear that erythroid precursors communicate their iron needs to the liver to influence the production of hepcidin and thus the amount of iron available for use. However, the mechanism by which erythroid cells accomplish this remains unclear and is an area of active investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18282520     DOI: 10.1016/S0070-2153(07)00006-3

Source DB:  PubMed          Journal:  Curr Top Dev Biol        ISSN: 0070-2153            Impact factor:   4.897


  26 in total

1.  Iron-mediated retinal degeneration in haemojuvelin-knockout mice.

Authors:  Jaya P Gnana-Prakasam; Amany Tawfik; Michelle Romej; Sudha Ananth; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2012-01-15       Impact factor: 3.857

Review 2.  Synthesis, delivery and regulation of eukaryotic heme and Fe-S cluster cofactors.

Authors:  Dulmini P Barupala; Stephen P Dzul; Pamela Jo Riggs-Gelasco; Timothy L Stemmler
Journal:  Arch Biochem Biophys       Date:  2016-01-16       Impact factor: 4.013

Review 3.  Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver.

Authors:  Elmar Aigner; Günter Weiss; Christian Datz
Journal:  World J Hepatol       Date:  2015-02-27

Review 4.  Maintaining Mammalian iron and oxygen homeostasis: sensors, regulation, and cross-talk.

Authors:  Ameen A Salahudeen; Richard K Bruick
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

5.  Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis.

Authors:  Alex H Gifford; Diana M Alexandru; Zhigang Li; Dana B Dorman; Lisa A Moulton; Katherine E Price; Thomas H Hampton; Mitchell L Sogin; Jonathan B Zuckerman; H Worth Parker; Bruce A Stanton; George A O'Toole
Journal:  J Cyst Fibros       Date:  2013-12-13       Impact factor: 5.482

6.  Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation.

Authors:  Zhaobao Yin; Haiyan Jiang; Eun-Sook Y Lee; Mingwei Ni; Keith M Erikson; Dejan Milatovic; Aaron B Bowman; Michael Aschner
Journal:  J Neurochem       Date:  2009-12-09       Impact factor: 5.372

7.  Absence of iron-regulatory protein Hfe results in hyperproliferation of retinal pigment epithelium: role of cystine/glutamate exchanger.

Authors:  Jaya P Gnana-Prakasam; Muthusamy Thangaraju; Kebin Liu; Yonju Ha; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2009-11-11       Impact factor: 3.857

8.  An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis.

Authors:  Ameen A Salahudeen; Joel W Thompson; Julio C Ruiz; He-Wen Ma; Lisa N Kinch; Qiming Li; Nick V Grishin; Richard K Bruick
Journal:  Science       Date:  2009-09-17       Impact factor: 47.728

Review 9.  A general map of iron metabolism and tissue-specific subnetworks.

Authors:  Valerie Hower; Pedro Mendes; Frank M Torti; Reinhard Laubenbacher; Steven Akman; Vladmir Shulaev; Suzy V Torti
Journal:  Mol Biosyst       Date:  2009-03-06

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.